Income Statement Brainlab SE

Stocks

BNLB

DE0005207906

End-of-day quote Deutsche Boerse AG Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

25/02	Brainlab SE and Precision NeuroMed Announce Strategic Partnership to Standardize and Scale Precision Drug Delivery to the Brain	CI
20/25/20	Marine Shipbuilder TKMS Makes Spectacular Stock Market Debut	DP

1deb2b45c55f8635.D-wA3nErGQ4cRWXpBCuvlwS2jjnmWny2r0VgfVBUbaw.QKo36TAcXWBMMCHccmripkX_-0qNakjh9ywxFRY6KeE7wW_uBRN_UX0wFg

Published financial data: BRAINLAB SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024
Revenues	36Cr	36Cr	43Cr	47Cr
Total Revenues	36Cr	36Cr	43Cr	47Cr
Cost of Goods Sold, Total	14Cr	15Cr	16Cr	18Cr
Gross Profit	21Cr	22Cr	27Cr	29Cr
Selling General & Admin Expenses, Total	15Cr	17Cr	18Cr	19Cr
R&D Expenses	5.37Cr	6.11Cr	7.5Cr	8.61Cr
Other Operating Expenses	-2.2Cr	-1.5Cr	-1.46Cr	-92.05L
Other Operating Expenses, Total	18Cr	21Cr	24Cr	27Cr
Operating Income	3.72Cr	50.21L	2.33Cr	2.35Cr
Interest Expense, Total	-36.74L	-53.13L	-63.68L	-1.06Cr
Interest And Investment Income	96T	13.23L	6L	7L
Net Interest Expenses	-35.78L	-39.9L	-58.11L	-98.61L
Income (Loss) On Equity Invest.	2L	52.1L	-3L	-16.92L
Currency Exchange Gains (Loss)	1L	-23.31L	-51L	-82.99L
Other Non Operating Income (Expenses)	-	-	-28.97L	-19.47L
EBT, Excl. Unusual Items	3.39Cr	39.1L	92.29L	17.33L
Impairment of Goodwill	-	-	-51.32L	-1.07Cr
Other Unusual Items	3L	2L	-	30.6L
EBT, Incl. Unusual Items	3.42Cr	41.45L	40.97L	-59.34L
Income Tax Expense	1.19Cr	9L	1.47Cr	75L
Earnings From Continuing Operations	2.23Cr	32.94L	-1.06Cr	-1.34Cr
Net Income to Company	2.23Cr	32.94L	-1.06Cr	-1.34Cr
Minority Interest	-	-98T	-87T	-6L
Net Income - (IS)	2.23Cr	31.96L	-1.07Cr	-1.41Cr
Net Income to Common Incl Extra Items	2.23Cr	31.96L	-1.07Cr	-1.41Cr
Net Income to Common Excl. Extra Items	2.23Cr	31.96L	-1.07Cr	-1.41Cr
Per Share Items
Net EPS - Basic	1.18	0.17	-0.57	-0.75
Basic EPS - Continuing Operations	1.18	0.17	-0.57	-0.75
Basic Weighted Average Shares Outstanding	1.89Cr	1.89Cr	1.89Cr	1.89Cr
Net EPS - Diluted	1.18	0.17	-0.57	-0.75
Diluted EPS - Continuing Operations	1.18	0.17	-0.57	-0.75
Diluted Weighted Average Shares Outstanding	1.89Cr	1.89Cr	1.89Cr	1.89Cr
Normalized Basic EPS	1.12	0.12	0.3	0.02
Normalized Diluted EPS	1.12	0.12	0.3	0.02
Dividend Per Share	0.27	0.27	-	-
Payout Ratio	18.57	159.36	-	-
Supplemental Items
EBITDA	4.79Cr	1.72Cr	3.7Cr	3.65Cr
EBITA	4.03Cr	81.79L	2.73Cr	2.66Cr
EBIT	3.72Cr	50.21L	2.33Cr	2.35Cr
EBITDAR	4.83Cr	1.73Cr	3.72Cr	3.67Cr
Effective Tax Rate - (Ratio)	34.7	20.53	359.58	-126.39
Normalized Net Income	2.12Cr	23.46L	56.81L	5L
Interest on Long-Term Debt	8L	8L	8L	7L
Non-Cash Pension Expense	0	0	0	-2T
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	5.37Cr	6.28Cr	7.5Cr	8.61Cr
Net Rental Expense, Total	5L	1L	2L	2L
Imputed Operating Lease Interest Expense	-	32.08T	55.5T	65.75T
Imputed Operating Lease Depreciation	-	91.92T	2L	1L

Fiscal Period: September	2021	2022	2023	2024
Assets
Cash And Equivalents	8.59Cr	6.67Cr	8.63Cr	7.9Cr
Short Term Investments	31.8L	-	-	-
Total Cash And Short Term Investments	8.91Cr	6.67Cr	8.63Cr	7.9Cr
Accounts Receivable, Total	9.64Cr	11Cr	13Cr	15Cr
Other Receivables	52.19L	72.02L	72.51L	1.16Cr
Total Receivables	10Cr	11Cr	13Cr	16Cr
Inventory	4.88Cr	5.97Cr	6.48Cr	6.83Cr
Prepaid Expenses	89.43L	1.23Cr	1.37Cr	1.16Cr
Other Current Assets, Total	6L	14.34L	26.51L	44.03L
Total Current Assets	25Cr	25Cr	30Cr	32Cr
Gross Property Plant And Equipment	14Cr	15Cr	15Cr	15Cr
Accumulated Depreciation	-4.55Cr	-5.56Cr	-6.01Cr	-6.64Cr
Net Property Plant And Equipment	9.25Cr	9.84Cr	9.11Cr	8.54Cr
Long-term Investments	39.82L	30.62L	44.21L	1.4Cr
Goodwill	7.57Cr	10Cr	9.13Cr	6.77Cr
Other Intangibles, Total	2.2Cr	4.3Cr	17Cr	17Cr
Accounts Receivable Long-Term	2.88Cr	3.97Cr	4.61Cr	5.77Cr
Deferred Tax Assets Long-Term	89.54L	1.58Cr	1.07Cr	1.18Cr
Deferred Charges Long-Term	8.4Cr	11Cr	-	-
Other Long-Term Assets, Total	87.39L	59.59L	72.62L	81.19L
Total Assets	57Cr	67Cr	72Cr	73Cr
Liabilities
Accounts Payable, Total	2.5Cr	3.33Cr	3.27Cr	4.51Cr
Accrued Expenses, Total	-	-	3.93Cr	3.59Cr
Current Portion of Long-Term Debt	4.56Cr	3.9Cr	1Cr	1.65Cr
Current Portion of Leases	99.97L	1.14Cr	1.14Cr	1.24Cr
Current Income Taxes Payable	71.02L	1.28Cr	67.54L	67.63L
Unearned Revenue Current, Total	5.9Cr	6.98Cr	7.3Cr	7.56Cr
Other Current Liabilities	5.32Cr	6.71Cr	3.14Cr	1.48Cr
Total Current Liabilities	20Cr	23Cr	20Cr	21Cr
Long-Term Debt	4.04Cr	7.29Cr	17Cr	21Cr
Long-Term Leases	5.43Cr	5.49Cr	5.06Cr	4.63Cr
Unearned Revenue Non Current	1.45Cr	1.81Cr	1.74Cr	1.64Cr
Pension & Other Post Retirement Benefits	-	-	-	46.61L
Deferred Tax Liability Non Current	2.9Cr	3.57Cr	4.29Cr	4.73Cr
Other Non Current Liabilities	1.74Cr	2.22Cr	1.7Cr	1.13Cr
Total Liabilities	36Cr	44Cr	51Cr	54Cr
Common Stock, Total	1.89Cr	1.89Cr	1.89Cr	1.89Cr
Additional Paid In Capital	3.25Cr	3.25Cr	3.25Cr	-
Retained Earnings	16Cr	15Cr	14Cr	13Cr
Comprehensive Income and Other	1.06Cr	2.6Cr	1.65Cr	4.66Cr
Total Common Equity	22Cr	23Cr	21Cr	19Cr
Minority Interest	-	30.34L	31.21L	37.58L
Total Equity	22Cr	23Cr	21Cr	19Cr
Total Liabilities And Equity	57Cr	67Cr	72Cr	73Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.89Cr	1.89Cr	1.89Cr	1.89Cr
ECS Total Common Shares Outstanding	1.89Cr	1.89Cr	1.89Cr	1.89Cr
Book Value / Share	11.57	12.06	10.97	10.11
Tangible Book Value	12Cr	8.3Cr	-4.97Cr	-4.58Cr
Tangible Book Value Per Share	6.39	4.4	-2.63	-2.43
Total Debt	15Cr	18Cr	25Cr	28Cr
Net Debt	6.12Cr	11Cr	16Cr	20Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-4L	-2L	-3L	-4L
Debt Equivalent Oper. Leases	38.4L	10L	18.48L	16.4L
Minority Interest, Total (Incl. Fin. Div)	-	30.34L	31.21L	37.58L
Equity Method Investments, Total	25.98L	-	79T	51.26L
Account Code - Inventory Valuation	-	3	3	3
Inventories - Raw Materials, Total	56.65L	67.15L	80.01L	72.05L
Inventories - Work In Process, Total	-	14.35L	44.47L	41.23L
Inventories - Finished Goods, Total	4.32Cr	5.16Cr	5.24Cr	5.69Cr
Land - (BS)	1.7Cr	2.11Cr	2.14Cr	2.12Cr
Machinery, Total	5.51Cr	6.6Cr	6.74Cr	7.16Cr
Full Time Employees	-	2.18T	2.27T	2.37T

Fiscal Period: September	2021	2022	2023	2024
Net Income	2.23Cr	31.96L	-1.07Cr	-1.41Cr
Depreciation & Amortization - CF	1.82Cr	2.1Cr	2.26Cr	2.32Cr
Amortization of Goodwill and Intangible Assets - (CF)	31.07L	31.58L	39.19L	31.17L
Depreciation & Amortization, Total	2.13Cr	2.42Cr	2.65Cr	2.63Cr
Amortization of Deferred Charges, Total - (CF)	1.92Cr	2.13Cr	3.09Cr	3.44Cr
(Gain) Loss From Sale Of Asset	-70.06L	-1.27Cr	-5L	-36.59L
Asset Writedown & Restructuring Costs	-	-	51.32L	1.11Cr
(Income) Loss On Equity Investments - (CF)	-2L	-52.1L	3L	16.92L
Other Operating Activities, Total	-43.88L	25T	1.33Cr	88.8L
Change In Accounts Receivable	-1.02Cr	-1.59Cr	-3.42Cr	-3.32Cr
Change In Inventories	-1.11Cr	-36.36L	-67.61L	-34.28L
Change In Accounts Payable	43.53L	42.44L	-11.79L	80T
Change in Unearned Revenues	-4L	97.72L	39.23L	13.72L
Change In Deferred Taxes	97T	54.62L	2L	-
Change in Other Net Operating Assets	32.28L	52.18L	-21.87L	-90.43L
Cash from Operations	3.72Cr	3.6Cr	2.48Cr	2.04Cr
Capital Expenditure	-96.47L	-82.72L	-83.02L	-78.78L
Sale of Property, Plant, and Equipment	95T	2L	5L	14.1L
Cash Acquisitions	-1.23Cr	-1.69Cr	-69T	-
Divestitures	-	-	-	2.01Cr
Sale (Purchase) of Intangible assets	-3.4Cr	-4.26Cr	-5.32Cr	-5.08Cr
Investment in Marketable and Equity Securities, Total	36.17L	32.61L	-11.63L	-1.5Cr
Other Investing Activities, Total	-	-	-1T	-
Cash from Investing	-5.22Cr	-6.43Cr	-6.22Cr	-5.22Cr
Long-Term Debt Issued, Total	3Cr	10Cr	9.7Cr	15Cr
Total Debt Issued	3Cr	10Cr	9.7Cr	15Cr
Long-Term Debt Repaid, Total	-1.82Cr	-9.17Cr	-3.78Cr	-13Cr
Total Debt Repaid	-1.82Cr	-9.17Cr	-3.78Cr	-13Cr
Common Dividends Paid	-41.5L	-50.93L	-	-
Common & Preferred Stock Dividends Paid	-41.5L	-50.93L	-	-
Cash from Financing	76.64L	44.93L	5.92Cr	2.57Cr
Foreign Exchange Rate Adjustments	3L	46.79L	-22.72L	-
Miscellaneous Cash Flow Adjustments	-	-	-	-12.06L
Net Change in Cash	-69.42L	-1.92Cr	1.96Cr	-73.46L
Supplemental Items
Cash Interest Paid	23.77L	24.55L	60.31L	73.93L
Cash Income Tax Paid (Refund)	1.78Cr	28.08L	45.61L	42.94L
Levered Free Cash Flow	-	57.72L	-1.99Cr	-1.84Cr
Unlevered Free Cash Flow	-	90.92L	-1.59Cr	-1.18Cr
Change In Net Working Capital	-	-1.14Cr	2.64Cr	2.85Cr
Net Debt Issued / Repaid	1.18Cr	95.86L	5.92Cr	2.57Cr

Fiscal Period: September	2021	2022	2023	2024
Profitability
Return on Assets	-	0.51	2.11	2.03
Return on Total Capital	-	0.81	3.37	3.16
Return On Equity %	-	1.47	-4.83	-6.64
Return on Common Equity	-	1.43	-4.94	-7.07
Margin Analysis
Gross Profit Margin %	59.93	59.35	62.45	62.49
SG&A Margin	40.72	45.3	42.92	41.13
EBITDA Margin %	13.35	4.72	8.62	7.76
EBITA Margin %	11.25	2.25	6.35	5.67
EBIT Margin %	10.38	1.38	5.44	5
Income From Continuing Operations Margin %	6.23	0.9	-2.48	-2.86
Net Income Margin %	6.23	0.88	-2.5	-2.99
Net Avail. For Common Margin %	6.23	0.88	-2.5	-2.99
Normalized Net Income Margin	5.91	0.64	1.32	0.1
Levered Free Cash Flow Margin	-	1.58	-4.62	-3.9
Unlevered Free Cash Flow Margin	-	2.5	-3.7	-2.5
Asset Turnover
Asset Turnover	-	0.59	0.62	0.65
Fixed Assets Turnover	-	3.82	4.53	5.33
Receivables Turnover (Average Receivables)	-	3.59	3.7	3.48
Inventory Turnover (Average Inventory)	-	2.73	2.59	2.65
Short Term Liquidity
Current Ratio	1.25	1.09	1.47	1.55
Quick Ratio	0.95	0.77	1.07	1.14
Operating Cash Flow to Current Liabilities	0.19	0.15	0.12	0.1
Days Sales Outstanding (Average Receivables)	-	101.71	98.66	105.26
Days Outstanding Inventory (Average Inventory)	-	133.79	141.04	138.07
Average Days Payable Outstanding	-	66.92	72.38	93.01
Cash Conversion Cycle (Average Days)	-	168.57	167.32	150.32
Long Term Solvency
Total Debt/Equity	68.89	77.29	117.07	144.59
Total Debt / Total Capital	40.79	43.6	53.93	59.12
LT Debt/Equity	43.41	55.42	106.86	129.75
Long-Term Debt / Total Capital	25.7	31.26	49.23	53.05
Total Liabilities / Total Assets	61.97	65.48	70.68	73.49
EBIT / Interest Expense	10.13	0.95	3.67	2.23
EBITDA / Interest Expense	15.92	5.5	7.83	4.72
(EBITDA - Capex) / Interest Expense	13.3	3.94	6.53	3.97
Total Debt / EBITDA	2.57	6.1	4.93	5.64
Net Debt / EBITDA	1.05	3.82	3.2	4.06
Total Debt / (EBITDA - Capex)	3.08	8.51	5.92	6.7
Net Debt / (EBITDA - Capex)	1.25	5.32	3.84	4.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	1.61	17.82	9.56
Gross Profit, 1 Yr. Growth %	-	0.62	23.98	9.64
EBITDA, 1 Yr. Growth %	-	-64.06	437.62	3.19
EBITA, 1 Yr. Growth %	-	-79.72	-1.37T	3.94
EBIT, 1 Yr. Growth %	-	-86.51	-540.29	8.34
Earnings From Cont. Operations, 1 Yr. Growth %	-	-85.26	-422.86	26.32
Net Income, 1 Yr. Growth %	-	-85.7	-435.48	31.12
Normalized Net Income, 1 Yr. Growth %	-	-88.94	127.92	-90.18
Diluted EPS Before Extra, 1 Yr. Growth %	-	-85.64	-436.44	31.58
Accounts Receivable, 1 Yr. Growth %	-	10.63	17.62	15.67
Inventory, 1 Yr. Growth %	-	22.35	8.52	5.29
Net Property, Plant and Equip., 1 Yr. Growth %	-	6.33	-7.42	-6.27
Total Assets, 1 Yr. Growth %	-	16.39	7.26	2.37
Tangible Book Value, 1 Yr. Growth %	-	-31.16	113.22	-7.94
Common Equity, 1 Yr. Growth %	-	4.26	-9.06	-7.85
Cash From Operations, 1 Yr. Growth %	-	-3.38	-31.03	-17.79
Capital Expenditures, 1 Yr. Growth %	-	-14.25	0.36	-5.11
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-1.51T	-24.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-701.16	-42.46
Dividend Per Share, 1 Yr. Growth %	-	0	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	9.42	13.62
Gross Profit, 2 Yr. CAGR %	-	-	11.69	16.59
EBITDA, 2 Yr. CAGR %	-	-	-12.09	130.31
EBITA, 2 Yr. CAGR %	-	-	-17.77	252.56
EBIT, 2 Yr. CAGR %	-	-	-20.8	110.67
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-31.02	101.95
Net Income, 2 Yr. CAGR %	-	-	-30.74	109.74
Normalized Net Income, 2 Yr. CAGR %	-	-	-48.23	-57.13
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-30.5	110.4
Accounts Receivable, 2 Yr. CAGR %	-	-	14.07	16.64
Inventory, 2 Yr. CAGR %	-	-	15.22	6.89
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-0.78	-6.85
Total Assets, 2 Yr. CAGR %	-	-	11.73	4.79
Tangible Book Value, 2 Yr. CAGR %	-	-	-35.79	40.11
Common Equity, 2 Yr. CAGR %	-	-	-2.63	-8.46
Cash From Operations, 2 Yr. CAGR %	-	-	-18.37	-24.7
Capital Expenditures, 2 Yr. CAGR %	-	-	-7.23	-2.41
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	261.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	111.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	9.47
Gross Profit, 3 Yr. CAGR %	-	-	-	11
EBITDA, 3 Yr. CAGR %	-	-	-	-8.65
EBITA, 3 Yr. CAGR %	-	-	-	-12.9
EBIT, 3 Yr. CAGR %	-	-	-	-14.17
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	-15.61
Net Income, 3 Yr. CAGR %	-	-	-	-14.32
Normalized Net Income, 3 Yr. CAGR %	-	-	-	-72.15
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-14.02
Accounts Receivable, 3 Yr. CAGR %	-	-	-	14.6
Inventory, 3 Yr. CAGR %	-	-	-	11.81
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-2.65
Total Assets, 3 Yr. CAGR %	-	-	-	8.52
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-27.59
Common Equity, 3 Yr. CAGR %	-	-	-	-4.4
Cash From Operations, 3 Yr. CAGR %	-	-	-	-18.17
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-6.53